BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 34885241)

  • 1. Multifaceted Roles of Chemokines and Chemokine Receptors in Tumor Immunity.
    Matsuo K; Yoshie O; Nakayama T
    Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T Helper (Th) Cell Profiles in Pregnancy and Recurrent Pregnancy Losses: Th1/Th2/Th9/Th17/Th22/Tfh Cells.
    Wang W; Sung N; Gilman-Sachs A; Kwak-Kim J
    Front Immunol; 2020; 11():2025. PubMed ID: 32973809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells exposed to extracellular adenosine triphosphate acquire the migratory properties of mature cells and show a reduced capacity to attract type 1 T lymphocytes.
    la Sala A; Sebastiani S; Ferrari D; Di Virgilio F; Idzko M; Norgauer J; Girolomoni G
    Blood; 2002 Mar; 99(5):1715-22. PubMed ID: 11861288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance.
    Lee BC; Lee J
    Biochim Biophys Acta; 2014 Mar; 1842(3):446-62. PubMed ID: 23707515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of innate lymphocytes in infection and inflammation.
    Koyasu S; Moro K
    Front Immunol; 2012; 3():101. PubMed ID: 22783250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically feasible approaches to potentiating cancer cell-based immunotherapies.
    Seledtsov VI; Goncharov AG; Seledtsova GV
    Hum Vaccin Immunother; 2015; 11(4):851-69. PubMed ID: 25933181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8
    Farhood B; Najafi M; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay of Chemokines Receptors, Toll-like Receptors, and Host Immunological Pathways.
    Chu YT; Liao MT; Tsai KW; Lu KC; Hu WC
    Biomedicines; 2023 Aug; 11(9):. PubMed ID: 37760825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer.
    Yamamoto M; Kamigaki T; Yamashita K; Hori Y; Hasegawa H; Kuroda D; Moriyama H; Nagata M; Ku Y; Kuroda Y
    Oncol Rep; 2009 Aug; 22(2):337-43. PubMed ID: 19578774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation and Regulation of T
    Basu A; Ramamoorthi G; Albert G; Gallen C; Beyer A; Snyder C; Koski G; Disis ML; Czerniecki BJ; Kodumudi K
    Front Immunol; 2021; 12():669474. PubMed ID: 34012451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression.
    Stolk D; van der Vliet HJ; de Gruijl TD; van Kooyk Y; Exley MA
    Front Immunol; 2018; 9():1990. PubMed ID: 30298063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine.
    Imai T; Nagira M; Takagi S; Kakizaki M; Nishimura M; Wang J; Gray PW; Matsushima K; Yoshie O
    Int Immunol; 1999 Jan; 11(1):81-8. PubMed ID: 10050676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate and adaptive immunity in inflammatory bowel disease.
    Geremia A; Biancheri P; Allan P; Corazza GR; Di Sabatino A
    Autoimmun Rev; 2014 Jan; 13(1):3-10. PubMed ID: 23774107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral regulatory T cells: markers, subsets and their impact on anti-tumor immunity.
    Yano H; Andrews LP; Workman CJ; Vignali DAA
    Immunology; 2019 Jul; 157(3):232-247. PubMed ID: 31087644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of T helper 17 and regulatory T cells in tumor microenvironment.
    Najafi S; Mirshafiey A
    Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):16-24. PubMed ID: 30714422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate and adaptive immune pathways to tolerance.
    Thornton CA; Morgan G
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():45-57; discussion 57-61, 251-7. PubMed ID: 19710514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immune potential and immunopathology of cytokine-producing B cell subsets: a comprehensive review.
    Bao Y; Cao X
    J Autoimmun; 2014 Dec; 55():10-23. PubMed ID: 24794622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+CD25+Foxp3+ T regulatory cells, Th1 (CCR5, IL-2, IFN-γ) and Th2 (CCR4, IL-4, Il-13) type chemokine receptors and intracellular cytokines in children with common variable immunodeficiency.
    Kutukculer N; Azarsiz E; Aksu G; Karaca NE
    Int J Immunopathol Pharmacol; 2016 Jun; 29(2):241-51. PubMed ID: 26684629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity.
    Sebastiani S; Allavena P; Albanesi C; Nasorri F; Bianchi G; Traidl C; Sozzani S; Girolomoni G; Cavani A
    J Immunol; 2001 Jan; 166(2):996-1002. PubMed ID: 11145678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells.
    Penna G; Vulcano M; Sozzani S; Adorini L
    Hum Immunol; 2002 Dec; 63(12):1164-71. PubMed ID: 12480260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.